Investing.com -- Trevi Therapeutics, Inc. (NASDAQ:TRVI) shares fell 10% in after-hours trading Thursday following the company’s announcement of a proposed public offering of common stock.

Alcoa Corporation (NYSE:AA) reported first quarter adjusted earnings per share of $1.40, missing analyst estimates of $1.47, as shipment delays and lower volumes weighed on results. Revenue of $3.19 ...

The trucking company now expects adjusted earnings per share for the first quarter of 2026 to range from $0.08 to $0.10, down sharply from its previous guidance of $0.28 to $0.32. The revised outlook ...

First Financial Bankshares (NASDAQ:FFIN) reported first quarter earnings that exceeded analyst expectations, with adjusted earnings per share of $0.50 compared to ...

The company repurchased approximately 802,000 shares for $63.3 million during the quarter and increased its quarterly dividend 8.5% to $0.64 per share from $0.59. Tangible book value per share grew to ...

NiSource Inc. (NYSE:NI) shares rose 3% in after-hours trading Thursday following the announcement of strategic energy ...

"Westamerica’s first quarter 2026 results benefited from the Company’s valuable low-cost deposit base," said Chairman, President and CEO David Payne. "Operating expenses remained well controlled at 42 ...

Netflix first-quarter profit beats estimates on strong subscription ...

Asia’s highly energy-intensive economy and its reliance on Middle East fuel will keep the region exposed to fallout from the war, Srinivasan said. The use of oil and gas amounts to about 4% of Asia’s ...

Investing.com - The Trump administration is preparing a trade agreement with select partners to establish a critical minerals market that includes a price floor designed to prevent Chinese dumping, ...

Investing.com -- OpenAI on Thursday launched GPT-Rosalind, an artificial intelligence model designed to support research in biology, drug discovery, and translational medicine.

Investing.com -- President Donald Trump announced Thursday the nomination of Dr. Erica Schwartz as director of the Centers for Disease Control and Prevention.